Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Here's the Simple Reason Why Multiple Sclerosis Drugs Cost So Much


Here's the Simple Reason Why Multiple Sclerosis Drugs Cost So Much

Two members of the U.S. House of Representatives Committee on Oversight and Government Reform want to know why the prices of multiple sclerosis (MS) drugs are so high. Rep. Elijah Cummings (D-Md.) and Rep. Peter Welch (D-Vt.) have sent letters to seven drugmakers, including Biogen (NASDAQ: BIIB) and Teva Pharmaceutical Industries (NYSE: TEVA), asking for information about factors related to pricing for their MS products. 

These letters appear to be an opening salvo in what Cummings and Welch vow will be a full investigation into pricing of MS drugs. I don't think an investigation is needed at all, though. There's a simple reason why these drugs cost so much: It's just the way our system works.   

Image source: Getty Images.

Continue reading


Source: Fool.com

Teva Pharmaceutical Industries Ltd ADR Stock

€12.80
-1.540%
A loss of -1.540% shows a downward development for Teva Pharmaceutical Industries Ltd ADR.
Teva Pharmaceutical Industries Ltd ADR is currently one of the favorites of our community with 11 Buy predictions and no Sell predictions.
As a result the target price of 13 € shows a slightly positive potential of 1.56% compared to the current price of 12.8 € for Teva Pharmaceutical Industries Ltd ADR.
Like: 0
Share

Comments